Showing results (131-140 of 220) with videos related to
Sort By:
Pageof 22
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|September 29, 2016
In vitro activity of tedizolid against Staphylococcus aureus and Streptococcus pneumoniae collected in 2013 and 2014 from sites in Latin American countries, Australia, New Zealand, and ChinaD J Biedenbach, S K Bouchillon, B Johnson, et al.Antimicrobial Agents and Chemotherapy|July 28, 2006
qnr prevalence in ceftazidime-resistant Enterobacteriaceae isolates from the United StatesA Robicsek, J Strahilevitz, D F Sahm, et al.Antimicrobial Agents and Chemotherapy|June 28, 2005
Broader distribution of plasmid-mediated quinolone resistance in the United StatesA Robicsek, D F Sahm, J Strahilevitz, et al.The American Journal of Gastroenterology|September 1, 1993
Long-term management of Crohn's disease with mesalamine capsules (Pentasa). Pentasa Crohn's Disease Compassionate Use Study GroupS B Hanauer, E L Krawitt, M Robinson, et al.Journal of Clinical Microbiology|October 1, 1992
New vancomycin disk diffusion breakpoints for enterococci. The National Committee for Clinical Laboratory Standards Working Group on EnterococciJ M Swenson, M J Ferraro, D F Sahm, et al.Antimicrobial Agents and Chemotherapy|May 1, 1995
In vitro activities of various beta-lactam antimicrobial agents against clinical isolates of Escherichia coli and Klebsiella spp. resistant to oxyimino cephalosporinsB D Jett, D J Ritchie, R Reichley, et al.Antimicrobial Agents and Chemotherapy|April 17, 2001
Multidrug-resistant urinary tract isolates of Escherichia coli: prevalence and patient demographics in the United States in 2000D F Sahm, C Thornsberry, D C Mayfield, et al.Journal of Clinical Microbiology|September 1, 1991
Factors influencing determination of high-level aminoglycoside resistance in Enterococcus faecalisD F Sahm, S Boonlayangoor, P C Iwen, et al.International Journal of Antimicrobial Agents|May 15, 2002
Ceftriaxone activity against Gram-positive and Gram-negative pathogens isolated in US clinical microbiology laboratories from 1996 to 2000: results from The Surveillance Network (TSN) Database-USAJ A Karlowsky, M E Jones, D C Mayfield, et al.The American Journal of Medicine|November 1, 1988
Chronic hepatitis: disease factors at diagnosis predictive of mortalityB A Lashner, R B Jonas, H S Tang, et al.Pageof 22